Kidswell Bio Corp. engages in the research and development of biopharmaceutical products. Its products include antibodies, oligosaccharides, small interfering ribonucleic acids, proteins, and peptides. The company was founded on March 1, 2001 and is headquartered in Tokyo, Japan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company